Literature DB >> 10620110

Inhibition of melanin synthesis by cystamine in human melanoma cells.

L Qiu1, M Zhang, R A Sturm, B Gardiner, I Tonks, G Kay, P G Parsons.   

Abstract

In studies to determine whether pigmentation can be regulated physiologically by thiols, human melanoma cells (MM418c5) and melanocytes were found to become depigmented when cultured continuously in 50 microM cystamine. Cystamine was depleted from the culture medium and the treatment was nontoxic and reversible. Cysteamine, dithiothreitol, and phenylthiourea were less effective, and glutathione, cysteine, and cystine were inactive. Tyrosinase (dopa oxidase) activity was not greatly affected except for induction of a lag period. In contrast, tyrosinase activity in an amelanotic melanoma cell line (MM96L) was rapidly inhibited without consumption of cystamine/cysteamine, in association with the generation of free thiol in the culture medium, and could be enhanced by the cystine transport inhibitor, glutamate. Tyrosinase expressed by a recombinant vaccinia virus was inhibited by cystamine treatment of MM96L and HeLa cells. Cystamine treatment lowered the degree of cross-linking of the pigmentation antigen gp75/TRP-1 in MM418c5 cells. Tyrosinase protein and mRNA levels in MM418c5 cells were not affected by cystamine. The results show that cystamine at a concentration close to physiologic levels has multiple effects on the melanogenic pathway. In amelanotic cells, tyrosinase has a short half-life and is readily inhibited by cystamine/cysteamine whereas tyrosinase in the more mature melanosomes of the pigmented cell appears to be less accessible to proteolytic and thiol attack. Inhibition of melanin synthesis in the latter cell type may arise to a significant degree from reduction of cystamine to cysteamine, which sequesters quinones.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620110     DOI: 10.1046/j.1523-1747.2000.00826.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  Therapeutic effects of cystamine in a murine model of Huntington's disease.

Authors:  Alpaslan Dedeoglu; James K Kubilus; Thomas M Jeitner; Samantha A Matson; Misha Bogdanov; Neil W Kowall; Wayne R Matson; Arthur J L Cooper; Rajiv R Ratan; M Flint Beal; Steven M Hersch; Robert J Ferrante
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

2.  A new continuous spectrophotometric assay method for DOPA oxidase activity of tyrosinase.

Authors:  Yong-Doo Park; Jae-Rin Lee; Kyung-Hee Park; Hwa-Sun Hahn; Myong-Joon Hahn; Jun-Mo Yang
Journal:  J Protein Chem       Date:  2003-07

3.  Cell density-dependent reduction of dihydroceramide desaturase activity in neuroblastoma cells.

Authors:  Stefka D Spassieva; Mehrdad Rahmaniyan; Jacek Bielawski; Christopher J Clarke; Jacqueline M Kraveka; Lina M Obeid
Journal:  J Lipid Res       Date:  2012-02-29       Impact factor: 5.922

4.  A Small Molecule Fluorogenic Probe for the Detection of Sphingosine in Living Cells.

Authors:  Andrew K Rudd; Neel Mittal; Esther W Lim; Christian M Metallo; Neal K Devaraj
Journal:  J Am Chem Soc       Date:  2020-10-12       Impact factor: 15.419

5.  Novel Chemically Modified Curcumin (CMC) Derivatives Inhibit Tyrosinase Activity and Melanin Synthesis in B16F10 Mouse Melanoma Cells.

Authors:  Shilpi Goenka; Francis Johnson; Sanford R Simon
Journal:  Biomolecules       Date:  2021-04-30

6.  Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.

Authors:  Tonino Alonzi; Alessandra Aiello; Linda Petrone; Saeid Najafi Fard; Manuela D'Eletto; Laura Falasca; Roberta Nardacci; Federica Rossin; Giovanni Delogu; Concetta Castilletti; Maria Rosaria Capobianchi; Giuseppe Ippolito; Mauro Piacentini; Delia Goletti
Journal:  Cells       Date:  2021-12-24       Impact factor: 6.600

7.  Involvement of Transglutaminase-2 in α-MSH-Induced Melanogenesis in SK-MEL-2 Human Melanoma Cells.

Authors:  Hyun Ji Kim; Hye Ja Lee; Mi Kyung Park; Kyung Jin Gang; Hyun Jung Byun; Jeong Ho Park; Mi Kyung Kim; Soo Youl Kim; Chang Hoon Lee
Journal:  Biomol Ther (Seoul)       Date:  2014-05       Impact factor: 4.634

8.  Plasma Thiol Levels are Associated with Disease Severity in Nonsegmental Vitiligo.

Authors:  Gulsen Akoglu; Salim Neselioglu; Eda Karaismailoglu; Akin Aktas; Ozcan Erel
Journal:  Indian J Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.494

Review 9.  Metabolic Basis and Clinical Evidence for Skin Lightening Effects of Thiol Compounds.

Authors:  Yong Chool Boo
Journal:  Antioxidants (Basel)       Date:  2022-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.